These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 24908933)
1. [ASCO highlights in the treatment of metastatic melanoma]. Hertlein A Med Monatsschr Pharm; 2014 May; 37(5):183-4. PubMed ID: 24908933 [No Abstract] [Full Text] [Related]
12. From targeted monotherapy to combined BRAF-MEK inhibitors and integrated genome analysis for melanoma treatment. Roukos DH; Papaloukas C; Tzaphlidou M Future Oncol; 2013 Jan; 9(1):5-8. PubMed ID: 23252557 [No Abstract] [Full Text] [Related]
13. Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor. Curry JL; Falchook GS; Hwu WJ; Torres-Cabala CA; Duvic M; Tetzlaff MT; Prieto VG Am J Dermatopathol; 2013 Feb; 35(1):125-8. PubMed ID: 22878367 [TBL] [Abstract][Full Text] [Related]
14. Cancer research. Melanoma drug vindicates targeted approach. Garber K Science; 2009 Dec; 326(5960):1619. PubMed ID: 20019269 [No Abstract] [Full Text] [Related]
15. Hepatocyte growth factor in the neighborhood reverses resistance to BRAF inhibitor in melanoma. Nickoloff BJ; Vande Woude G Pigment Cell Melanoma Res; 2012 Nov; 25(6):758-61. PubMed ID: 22974232 [No Abstract] [Full Text] [Related]
16. Narrative review: BRAF opens the door for therapeutic advances in melanoma. Flaherty KT Ann Intern Med; 2010 Nov; 153(9):587-91. PubMed ID: 21041578 [TBL] [Abstract][Full Text] [Related]
17. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies. Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676 [TBL] [Abstract][Full Text] [Related]
19. Targeted treatment for melanoma. Monga M; Abraham J Expert Rev Anticancer Ther; 2012 Sep; 12(9):1113-5. PubMed ID: 23098110 [No Abstract] [Full Text] [Related]
20. Is there a role for single-agent BRAF inhibition in melanoma? Chmielowski B Clin Adv Hematol Oncol; 2017 Feb; 15(2):108-110. PubMed ID: 28398279 [No Abstract] [Full Text] [Related] [Next] [New Search]